Time-varying overdispersion of SARS-CoV-2 transmission during the periods when different variants of concern were circulating in Japan.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 08 2023
Historique:
received: 06 12 2022
accepted: 30 06 2023
medline: 17 8 2023
pubmed: 15 8 2023
entrez: 14 8 2023
Statut: epublish

Résumé

Japan has implemented a cluster-based approach for coronavirus disease 2019 (COVID-19) from the pandemic's beginning based on the transmission heterogeneity (overdispersion) of severe acute respiratory coronavirus 2 (SARS-CoV-2). However, studies analyzing overdispersion of transmission among new variants of concerns (VOCs), especially for Omicron, were limited. Thus, we aimed to clarify how the transmission heterogeneity has changed with the emergence of VOCs (Alpha, Delta, and Omicron) using detailed contact tracing data in Yamagata Prefecture, Japan. We estimated the time-varying dispersion parameter ([Formula: see text]) by fitting a negative binomial distribution for each transmission generation. Our results showed that even after the emergence of VOCs, there was transmission heterogeneity of SARS-CoV-2, with changes in [Formula: see text] during each wave. Continuous monitoring of transmission dynamics is vital for implementing appropriate measures. However, a feasible and sustainable epidemiological analysis system should be established to make this possible.

Identifiants

pubmed: 37580339
doi: 10.1038/s41598-023-38007-x
pii: 10.1038/s41598-023-38007-x
pmc: PMC10425347
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13230

Informations de copyright

© 2023. Springer Nature Limited.

Références

Endo, A., Abbott, S., Kucharski, A. J. & Funk, S. Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China. Wellcome Open Res. 5, 67 (2020).
doi: 10.12688/wellcomeopenres.15842.3 pubmed: 32685698 pmcid: 7338915
Adam, D. C. et al. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nat. Med. https://doi.org/10.1038/s41591-020-1092-0 (2020).
doi: 10.1038/s41591-020-1092-0 pubmed: 32943787
Lloyd-Smith, J. O., Schreiber, S. J., Kopp, P. E. & Getz, W. M. Superspreading and the effect of individual variation on disease emergence. Nature 438, 355–359 (2005).
doi: 10.1038/nature04153 pubmed: 16292310 pmcid: 7094981
Sneppen, K., Nielsen, B. F., Taylor, R. J. & Simonsen, L. Overdispersion in COVID-19 increases the effectiveness of limiting nonrepetitive contacts for transmission control. Proc. Natl. Acad. Sci. U. S. A. 118, 1–6 (2021).
doi: 10.1073/pnas.2016623118
Kain, M. P., Childs, M. L., Becker, A. D. & Mordecai, E. A. Chopping the tail: How preventing superspreading can help to maintain COVID-19 control. Epidemics 34, 100430 (2021).
doi: 10.1016/j.epidem.2020.100430 pubmed: 33360871
Althouse, B. M. et al. Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control. PLoS Biol. 18, 1–13 (2020).
doi: 10.1371/journal.pbio.3000897
Oshitani, H. Cluster-based approach to Coronavirus Disease 2019 (COVID-19) response in Japan—February–April 2020. Jpn. J. Infect. Dis. 73, 491-493 (2020).
Ko, Y. K. et al. Secondary transmission of SARS-CoV-2 during the first two waves in Japan: Demographic characteristics and overdispersion. Int. J. Infect. Dis. 116, 365–373 (2022).
doi: 10.1016/j.ijid.2022.01.036 pubmed: 35066162 pmcid: 8772065
Ogata, T. et al. Increased Secondary Attack Rates among the Household Contacts of Patients with the Omicron Variant of the Coronavirus Disease 2019 in Japan. Int. J. Environ. Res. Public Health 19, 8068 (2022).
Jørgensen, S. B., Nygård, K., Kacelnik, O. & Telle, K. Secondary attack rates for omicron and delta variants of SARS-CoV-2 in Norwegian Households. JAMA J. Am. Med. Assoc. 327, 1610–1611 (2022).
doi: 10.1001/jama.2022.3780
Ryu, S., Kim, D., Lim, J.-S., Ali, S. T. & Cowling, B. Serial Interval and Transmission Dynamics during SARS-CoV-2 Delta Variant Predominance South Korea. Emerg. Infect. Dis. J. 28, 350 (2022).
Hwang, H. et al. Transmission Dynamics of the Delta Variant of SARS-CoV-2 Infections in South Korea. J. Infect. Dis. 225, 793–799 (2022).
doi: 10.1093/infdis/jiab586 pubmed: 34865022
Zhao, S., Guo, Z., Chong, M. K. C., He, D. & Wang, M. H. (2022) Superspreading potential of SARS-CoV-2 Delta variants under intensive disease control measures in China. J. Travel Med. 1:2. doi: https://doi.org/10.1093/jtm/taac025 .
Mikszewski, A., Stabile, L., Buonanno, G. & Morawska, L. Increased close proximity airborne transmission of the SARS-CoV-2 Delta variant. Sci. Total Environ. 816, 151499 (2022).
doi: 10.1016/j.scitotenv.2021.151499 pubmed: 34752865
Petros, B. A. et al. Early introduction and rise of the omicron severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant in highly vaccinated university populations. Clin. Infect. Dis. 2, 1–9 (2022).
Guo, Z. et al. Superspreading potential of COVID-19 outbreak seeded by Omicron variants of SARS-CoV-2 in Hong Kong. J. Travel. Med. 29, 049 (2022).
doi: 10.1093/jtm/taac049
Guo, Z. et al. Superspreading potential of infection seeded by the SARS-CoV-2 Omicron BA.1 variant in South Korea. J. Infect. 85, e77–e79. https://doi.org/10.1016/j.jinf.2022.05.041 (2022).
doi: 10.1016/j.jinf.2022.05.041 pubmed: 35659549 pmcid: 9158374
Wang, J. et al. Superspreading and heterogeneity in transmission of SARS, MERS, and COVID-19: A systematic review. Comput. Struct. Biotechnol. J. 19, 5039–5046 (2021).
doi: 10.1016/j.csbj.2021.08.045 pubmed: 34484618 pmcid: 8409018
Lewis, D. Why many countries failed at COVID contact-tracing-but some got it right. Nature 588(7838), 384–387 (2020).
doi: 10.1038/d41586-020-03518-4 pubmed: 33318682
Kazuaki, J., Mieko, K.-C. & Hitoshi, O. Response COVID-19. https://responsecovid19.org/japan/data/ .
New Coronavirus Infectious Disease Portal Site, Yamagata, Japan. https://www-pref-yamagata-jp.translate.goog/090016/bosai/kochibou/kikikanri/covid19/shingata_corona.html?_x_tr_sl=ja&_x_tr_tl=en&_x_tr_hl=en .
Ninomiya, K., Kanamori, M., Ikeda, N. & Jindai, K. Integration of publicly available case-based data for real-time coronavirus disease 2019 risk assessment, Japan. West. Pacific Surveill. Response J. WPSAR 13, 1–6 (2022).
Adam, D. et al. (2022). Time-varying transmission heterogeneity of SARS and COVID-19 in Hong Kong. Reseach Sq. 1:17
Yusuke, K. et al. Replacement of SARS-CoV-2 strains with variants carrying N501Y and L452R mutations in Japan: An epidemiological surveillance assessment. West. Pacific Surveill. Response J. WPSAR 13, 1–10 (2022).
SARS-CoV-2 Genomic Surveillance (National Institute of Infectious Diseases). https://www.niid.go.jp/niid/images/cepr/covid-19/20220914_genome_surveillance.pdf .
Hall, V. et al. Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection. N. Engl. J. Med. 386, 1207–1220 (2022).
doi: 10.1056/NEJMoa2118691 pubmed: 35172051
Guo, Z. et al. A statistical framework for tracking the time-varying superspreading potential of COVID-19 epidemic. Epidemics 42, 100670 (2023).
doi: 10.1016/j.epidem.2023.100670 pubmed: 36709540 pmcid: 9872564
Brandal, L. T. et al. Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021. Eurosurveillance 26, 1–5 (2021).
doi: 10.2807/1560-7917.ES.2021.26.50.2101147
Espenhain, L. et al. Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021. Eurosurveillance 26, 1–7 (2021).
doi: 10.2807/1560-7917.ES.2021.26.50.2101146
NSW Health. Public Health Alert: Sydney Harbour Boat Cruise. https://www.health.nsw.gov.au/news/Pages/20211207_01.aspx (2021).
Lloyd-Smith, J. O. Maximum likelihood estimation of the negative binomial dispersion parameter for highly overdispersed data, with applications to infectious diseases. PLoS ONE 2, 1–8 (2007).
doi: 10.1371/journal.pone.0000180
Shi, Q. et al. Effective control of SARS-CoV-2 transmission in Wanzhou, China. Nat. Med. 27, 86–93 (2021).
doi: 10.1038/s41591-020-01178-5 pubmed: 33257893
Linton, N. M., Akhmetzhanov, A. R. & Nishiura, H. Localized end-of-outbreak determination for coronavirus disease 2019 (COVID-19): Examples from clusters in Japan. Int. J. Infect. Dis. 105, 286–292 (2021).
doi: 10.1016/j.ijid.2021.02.106 pubmed: 33662600 pmcid: 7919508
Johnson, K. D. et al. Disease momentum: Estimating the reproduction number in the presence of superspreading. Infect. Dis. Model. 6, 706–728 (2021).
pubmed: 33824936 pmcid: 8017919
Endo, A. et al. Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreaks [version 1; peer review: 2 Approved] Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working. Wellcome Open Res. 5, 1–15 (2021).
doi: 10.12688/wellcomeopenres.16344.3
Blumberg, S. & Lloyd-Smith, J. O. Inference of R0 and transmission heterogeneity from the size distribution of stuttering chains. PLoS Comput. Biol. 9, 1–17 (2013).
doi: 10.1371/journal.pcbi.1002993
Ministry of Health, Labour and Welfare. The 88th Meeting of the Advisory Board for COVID-19. https://www.mhlw.go.jp/content/10900000/000955794.pdf (2022) .
Ministry of Internal Affairs and Communications. Population and Households in Japan Derived from the Basic Resident Registration (by Municipality). https://www.soumu.go.jp/main_sosiki/jichi_gyousei/daityo/jinkou_jinkoudoutai-setaisuu.html .
e-Stat, Portal Site of Official Statistics of Japan. System of Social and Demographic Statistics, Statistical Observations of Municipalities 2021, Natural Environment. https://www.e-stat.go.jp/en/stat-search/files?page=1&layout=datalist&toukei=00200502&tstat=000001154566&cycle=0&tclass1=000001154567&tclass2val=0 .
Digital Agency. Vaccination Record System (VRS). https://info.vrs.digital.go.jp/ .
Seto, J. et al. Epidemiology of Coronavirus Disease 2019 in Yamagata Prefecture, Japan, January–May 2020: The importance of retrospective contact tracing. Jpn. J. Infect. Dis. 74, 522–529 (2021).
doi: 10.7883/yoken.JJID.2020.1073 pubmed: 33790065
Group (Cluster) Outbreak Situation of New Coronavirus Infectious Disease. https://www-pref-yamagata-jp.translate.goog/090016/kenfuku/kansensyou/covid19-outbreak.html?_x_tr_sl=ja&_x_tr_tl=en&_x_tr_hl=en .

Auteurs

Yura K Ko (YK)

Department of Virology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8575, Japan.

Yuki Furuse (Y)

Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Kanako Otani (K)

Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.

Masato Yamauchi (M)

Japan International Cooperation Agency, Tokyo, Japan.

Kota Ninomiya (K)

Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.

Mayuko Saito (M)

Department of Virology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8575, Japan.

Takeaki Imamura (T)

Department of Virology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8575, Japan.

Alex R Cook (AR)

Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.

Tadayuki Ahiko (T)

Division of Health and Welfare Planning, Yamagata Prefectural Government, Yamagata, Japan.

Shunji Fujii (S)

Murayama Public Health Center, Yamagata, Japan.

Yoshiharu Mori (Y)

Murayama Public Health Center, Yamagata, Japan.

Emiko Suzuki (E)

Mogami Public Health Center, Yamagata, Japan.

Keiko Yamada (K)

Okitama Public Health Center, Yamagata, Japan.

Yoshikazu Ashino (Y)

Shonai Public Health Center, Yamagata, Japan.

Hidetoshi Yamashita (H)

Yamagata City Institute of Public Health, Yamagata, Japan.

Yuichi Kato (Y)

Yamagata City Institute of Public Health, Yamagata, Japan.

Katsumi Mizuta (K)

Yamagata Prefectural Institute of Public Health, Yamagata, Japan.

Motoi Suzuki (M)

Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.

Hitoshi Oshitani (H)

Department of Virology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-Ku, Sendai, Miyagi, 980-8575, Japan. oshitanih@med.tohoku.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH